IP Library Granted Patent US 9,169,506
Granted Patent B2
US 9,169,506 · App. 14/476,790 · Granted Oct 27, 2015

Process for producing alpha-1,3-glucan polymer with reduced molecular weight

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,169,506
App. No.
14/476,790
Granted
Oct 27, 2015
Kind
B2
Abstract

A process for producing poly alpha-1,3-glucan with reduced molecular weight is disclosed. The process comprises contacting water, sucrose, a polar organic solvent, and a glucosyltransferase enzyme in a solution to produce poly alpha-1,3-glucan. This contacting step results in the production of poly alpha-1,3-glucan having a reduced molecular weight compared to the molecular weight of a poly alpha-1,3-glucan made in the absence of the polar organic solvent.

Claims (16)

1. A process for producing poly alpha-1,3-glucan comprising:

(a) contacting water, sucrose, a polar organic solvent, and a bacterial glucosyltransferase enzyme in a solution, wherein the glucosyltransferase enzyme synthesizes poly alpha-1,3-glucan, wherein a poly alpha-1,3-glucan is produced having a reduced molecular weight compared to the molecular weight of the poly alpha-1,3-glucan produced in the absence of the polar organic solvent, wherein the glucosyltransferase enzyme comprises an amino acid sequence that is at least 97% identical to SEQ ID NO: 12, SEQ ID NO: 2, SEQ ID NO: 32, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 14, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, or SEQ ID NO:30; and

(b) optionally, isolating the poly alpha-1,3-glucan produced in step (a); wherein the polar organic solvent is selected from the group consisting of acetonitrile, dimethyl sulfoxide, acetone, N,N-dimethylformamide, N,N-dimethylacetamide, tetrahydrofuran, propylene carbonate, sulfolane, hexamethylphosphoramide, 1,3-dimethyl-2-imidazolidinone, nitromethane, butanone, methanol, methyl formamide, ethanol, isopropanol, 1-propanol, tert-butyl alcohol, formamide, n-butanol, ethylene glycol, 2-methoxyethanol, 1-methoxy-2-propanol, glycerol, 1,2-propanediol, and 1,3-propanetriol.

2. The process of claim 1 , wherein the polar organic solvent is selected from the group consisting of acetonitrile, dimethyl sulfoxide, acetone, N,N-dimethylformamide, N,N-dimethylacetamide, tetrahydrofuran, propylene carbonate, sulfolane, methanol, methyl formamide, ethanol, isopropanol, 1-propanol, tert-butyl alcohol, and formamide.

3. The process of claim 1 , wherein the concentration of the polar organic solvent in the solution is about 2% to about 20% by volume.

4. The process of claim 3 , wherein the concentration of the polar organic solvent in the solution is about 10% by volume.

5. The process of claim 1 , wherein the solution has a temperature between about 5° C. to about 50° C.

6. The process of claim 1 , wherein the initial concentration of the sucrose in the solution is about 20 g/L to about 400 g/L.

7. The process of claim 1 , wherein the molecular weight of the poly alpha-1,3-glucan produced in step (a) is reduced by at least about 15%.

8. The process of claim 1 , wherein the molecular weight of the poly alpha-1,3-glucan produced in step (a) is reduced by at least about 50%.

9. The process of claim 1 , wherein the molecular weight is measured as weight average degree of polymerization (DPw).

10. The process of claim 9 , wherein the DPw of the poly alpha-1,3-glucan produced in step (a) is between about 40 and 800.

11. The process of claim 1 , wherein the glucosyltransferase enzyme comprises an amino acid sequence that is at least 98% identical to SEQ ID NO:12, SEQ ID NO:2, SEQ ID NO:32, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:14, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, or SEQ ID NO:30.

12. The process of claim 2 , wherein the glucosyltransferase enzyme comprises an amino acid sequence that is at least 98% identical to SEQ ID NO:12, SEQ ID NO:2, SEQ ID NO:32, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:14, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, or SEQ ID NO:30.

13. The process of claim 1 , wherein the glucosyltransferase enzyme comprises SEQ ID NO:12, SEQ ID NO:2, SEQ ID NO:32, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:14, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, or SEQ ID NO:30.

14. The process of claim 2 , wherein the glucosyltransferase enzyme comprises SEQ ID NO:12, SEQ ID NO:2, SEQ ID NO:32, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:14, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, or SEQ ID NO:30.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 28, 2020
From: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
To: NUTRITION & BIOSCIENCES USA 4, INC.
Reel/Frame 055028/0496 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENTITY TYPE PREVIOUSLY RECORDED AT REEL: 049879 FRAME: 0043. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 6, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
Reel/Frame 050300/0408 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2019
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
Reel/Frame 049879/0043 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2015
From: CAIMI, PERRY G.; HENNESSEY, SUSAN MARIE; NAGY, KEVIN D.; PAYNE, MARK S.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 034634/0605 →